相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Progress in the study of cancer-associated venous thromboembolism
Yuting Yao et al.
VASCULAR (2021)
Update on Guidelines for the Management of Cancer-Associated Thrombosis
Michael B. Streiff et al.
ONCOLOGIST (2021)
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer
Gary H. Lyman et al.
BLOOD ADVANCES (2021)
Combinatorial Treatment of Tinzaparin and Chemotherapy Can Induce a Significant Antitumor Effect in Pancreatic Cancer
Panagiotis Sarantis et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Direct Oral Anticoagulants: From Randomized Clinical Trials to Real-World Clinical Practice
Roberta Roberti et al.
FRONTIERS IN PHARMACOLOGY (2021)
The Impact of Thromboprophylaxis on the Survival of Patients with Advanced Pancreatic Cancer. The Pancreatic Cancer and Tinzaparin (PaCT) Study
Michalis Karamouzis et al.
CANCERS (2021)
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
Nigel S. Key et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Incidence of Venous Thromboembolism in Patients With Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes
Corinne Frere et al.
GASTROENTEROLOGY (2020)
Mechanisms of the Antitumor Activity of Low Molecular Weight Heparins in Pancreatic Adenocarcinomas
Alexandros Bokas et al.
CANCERS (2020)
Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy
Panagiotis Sarantis et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2020)
Primary Thromboprophylaxis in Pancreatic Cancer Patients: Why Clinical Practice Guidelines Should Be Implemented
Dominique Farge et al.
CANCERS (2020)
Real-World Data on Thromboprophylaxis in Active Cancer Patients: Where Are We? Are We Getting There?
Nikolaos Tsoukalas et al.
CANCERS (2020)
Direct oral anticoagulants compared to low-molecular-weight heparin for the treatment of cancer-associated thrombosis: Updated systematic review and meta-analysis of randomized controlled trials
Florian Moik et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)
Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysis
Ang Li et al.
THROMBOSIS RESEARCH (2019)
Randomised phase 3 study of adjuvant chemotherapy with or without nadroparin in patients with completely resected non-small-cell lung cancer: the NVALT-8 study
Harry J. M. Groen et al.
BRITISH JOURNAL OF CANCER (2019)
Cancer treatment and survivorship statistics, 2019
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
The non-anticoagulant promise of heparin and its mimetics
Barbara Mulloy
CURRENT OPINION IN PHARMACOLOGY (2019)
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
Dominique Farge et al.
LANCET ONCOLOGY (2019)
Non-Anticoagulant Low Molecular Weight Heparins for Pharmaceutical Applications
Yilan Ouyang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Anti-tumour effect of low molecular weight heparin in localised lung cancer: a phase III clinical trial
Guy Meyer et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
The Role of Tinzaparin in Oncology
Evangelos P. Dimakakos et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2018)
Randomized phase III trial of low-molecular-weight heparin enoxaparin in addition to standard treatment in small-cell lung cancer: the RASTEN trial
L. Ek et al.
ANNALS OF ONCOLOGY (2018)
High prevalence of incidental and symptomatic venous thromboembolic events in patients with advanced pancreatic cancer under palliative chemotherapy: A retrospective cohort study
Anne Katrin Berger et al.
PANCREATOLOGY (2017)
Tumor-stroma ratio (TSR) in non-small cell lung cancer (NSCLC) patients after lung resection is a prognostic factor for survival
Ke-Xing Xi et al.
JOURNAL OF THORACIC DISEASE (2017)
nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma: Canadian Subgroup Analysis of the Phase 3 MPACT Trial
Mustapha Tehfe et al.
ADVANCES IN THERAPY (2016)
DOACs - advances and limitations in real world
Lai Heng Lee
THROMBOSIS JOURNAL (2016)
Low molecular weight heparin tinzaparin antagonizes cisplatin resistance of ovarian cancer cells
Daniel Bastian Pfankuchen et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer A Randomized Clinical Trial
Agnes Y. Y. Lee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Efficacy of Prophylactic Low-Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial
Uwe Pelzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Venous thrombosis in pancreaticobiliary tract cancer: outcome and prognostic factors
A. C. Larsen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
ERKs in Cancer: Friends or Foes?
Xavier Deschenes-Simard et al.
CANCER RESEARCH (2014)
Epidemiology of cancer-associated venous thrombosis
Jasmijn F. Timp et al.
BLOOD (2013)
Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer
A. Maraveyas et al.
EUROPEAN JOURNAL OF CANCER (2012)
Randomized Trial of the Effect of the Low Molecular Weight Heparin Nadroparin on Survival in Patients With Cancer
Frederiek F. van Doormaal et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Symptomatic and incidental thromboembolism are both associated with mortality in pancreatic cancer
Laurel A. Menapace et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Tissue factor, angiogenesis and tumour progression
Joanne E. Bluff et al.
BREAST CANCER RESEARCH (2008)
Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patients
M. Mandala et al.
ANNALS OF ONCOLOGY (2007)
Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer
Alok A. Khorana et al.
CLINICAL CANCER RESEARCH (2007)
Low molecular weight heparin (LMWH) increases the efficacy of cisplatinum plus gemcitabine combination in advanced pancreatic cancer
Fikri Icli et al.
JOURNAL OF SURGICAL ONCOLOGY (2007)
Inhibition of CXCR4-mediated breast cancer metastasis: A potential role for heparinoids?
James R. Harvey et al.
CLINICAL CANCER RESEARCH (2007)
The effect of low molecular weight heparin on survival in patients with advanced malignancy
CPW Klerk et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer
M Altinbas et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Pancreatic cancer and thromboembolic disease
AA Khorana et al.
LANCET ONCOLOGY (2004)
分享论文
